On March 20, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
The Foreign-Trade Zones Board issued the following notices on March 21:
CBP issued the following releases on commercial trade and related matters:
A listing of recent Commerce Department antidumping and countervailing duty messages posted on CBP's website March 20, along with the case number(s) and CBP message number, is provided below. The messages are available by searching for the listed CBP message number at CBP's ADCVD Search page.
CBP will update ACE April 13 to enforce a shorter time frame requirement for filing type 86 entries, the agency said in a March 21 CSMS message. This announcement follows a Jan. 16 Federal Register notice that, among other changes, shortened the deadline for filing type 86 entries from 15 days after arrival -- the same as the deadline for formal entries -- to “upon or prior to arrival” of the shipment (see 2401120070).
The International Trade Commission published notices in the March 20 Federal Register on the following AD/CVD injury, Section 337 patent or other trade proceedings (any notices that warrant a more detailed summary will be in another ITT article):
The Commerce Department published notices in the Federal Register March 20 on the following AD/CV duty proceedings (any notices that announce changes to AD/CV duty rates, scope, affected firms or effective dates will be detailed in another ITT article):
On March 19, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
The Foreign-Trade Zones Board issued the following notices on March 20:
CBP issued the following releases on commercial trade and related matters: